期刊文献+

疏血通注射液对急诊室STEMI患者症状与心电图变化的影响 被引量:1

Effect and ECG Changes of Shuxuetong Injection on STEMI Patients in the Emergency Room
下载PDF
导出
摘要 目的探讨疏血通注射液对ST段抬高型急性心肌梗死(STEMI)患者急诊入院2h内的疗效。方法收集64例急诊STEMI患者,随机分为治疗组与对照组,每组各32例。对照组常规给予阿司匹林、氯吡格雷、低分子肝素等治疗;治疗组在对照组治疗的基础上加用疏血通注射液治疗,观察急诊室2h内患者症状与心电图变化情况。结果临床有效率治疗组为78.1%,对照组为53.1%,治疗组优于对照组(P<0.05)。结论疏血通注射液能有效改善再灌注治疗之前的STEMI临床症状,对STEMI的院内急救有积极辅助作用。 OBJECTIVE To discuss the effect of Shuxuetong injection on acute ST elevation myocardial infarc- tion (STEMI) patients emergency within 2 hours. METHODS Collected 64 cases of acute STEMI patients, which were divided into treatment and control groups by random, each group was 32. aspirin, clopidogrel and lowmolecular heparin were used in control group, on the basis of the control group, treatment groups combined with shuxuetong in- jection, Observed symptoms and electrocardiographic changes in patients with 2 hours in the emergency room. RESULTS In terms of clinical effectiveness , the treatment group was 78. 1%, control group was 53.1%, effect of treatment group is better than control group (P 〈 0. 05 ). CONCLUSION Shuxuetong injection can im- prove symptoms before reperfusion therapy for STEMI,which plays an important role in emergency.
出处 《海峡药学》 2017年第5期69-70,共2页 Strait Pharmaceutical Journal
基金 "重大新药创制"科技重大专项十二五第二批项目:创新药物研究开发技术平台建设-心脑血管疾病中药新药临床评价技术平台及规范研究 编号2012ZⅩ09303-010-001
关键词 ST段抬高型急性心肌梗死 疏血通注射液 STEMI Shuxuetong injection
  • 相关文献

参考文献4

二级参考文献29

  • 1张璇,肖兵,胡长林.疏血通注射液抗栓、溶栓作用机制的研究[J].中国中药杂志,2005,30(24):1950-1952. 被引量:135
  • 2Antman EM, Anbe DT, Armstrong PW, et al. ACC/ AHA guidelines for the management of patients with ST - elevation myocardial infarction:A report of the American College of Cardiology/ American Heart Association task force on practice( committee to revise the 1999 guidelines for the management of patients wit acute myocardial infarction)[J]. Am Coll Cardiol, 2004,44(3) : E1 - E211.
  • 3Kanse SM. Benzakour O. Kanthou C, etal. Induction of vascular SMC proliferation by urokinase indicales a novel mechanism of action in vasoproliferative disorders[J]. Arterioscler Thromb Vasc Bio, 1997, 17(11): 2848-2854.
  • 4Bochaton Piallat ML, Gabbiani G, Pepper MS, etal. Plasminogen activator expression in rat arterial smooth muscle cells depends on their phenotype and is modulated by cytokines[J]. Circ Res, 1998,82(10) : 1086- 1093.
  • 5May AE, Schmidt R, Kanse SM, et al. Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarction[J]. Blood, 2002,100(10):3611-3617.
  • 6Schneider J, Pollan M, Tejerina A, et al. Accumulation of uPAPAI - 1 complexes inside the tumour cells is associated with axillary nodal invasion in progesterone - receptor - positive early breast cancer [J].Br J Cancer, 2003,88(1): 96-101.
  • 7Strauss BH, Lau HK, Bowman KA, et al. Plasma urokinase anti gen and plasminogen activator inhibitor - 1 antigen level predict angiographic coronary restenosis[J]. Circulation, 1999, 100(15): 1616 - 1622.
  • 8Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:43
  • 9王吉耀.内科学[J].第二版.北京.人民卫生出版社2012:301.
  • 10郑振达,陈璘,赵长林,熊肇军,钱孝贤,彭朝权,周汉健,刘金来.内源性尿激酶及其受体在冠心病患者中的临床意义[J].中山大学学报(医学科学版),2008,29(1):87-90. 被引量:2

共引文献4253

同被引文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部